Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1218 U.S. listed China Stocks and Counting...
 Tracking 2944 U.S. Stocks and Counting...

 Bohai Pharmaceuticals (PINK:BOPH)

At least one VIE exists in the corporate structure

Company Description

Yantai Bohai Pharmaceuticals Group Co., Ltd. went public via a share exchange on January 5, with Link Resources.

Based in the city of Yantai, Shandong Province, China, Bohai is a profitable company principally engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on traditional Chinese medicine in China. Bohai’s medicines address common health problems such as rheumatism, rheumatoid arthritis, respiratory diseases, viral infections, gynecological diseases and cardio vascular issues. Bohai’s products are sold either by prescription through hospitals or Over the Counter through local pharmacies and retail drug store chains. Sales and distribution are managed and executed by about 260 sales representatives located in 20 offices throughout China as of November 2009. In a significant development, on December 1, 2009, two of Bohai’s lead products, Tongbi Capsules and Tablets and Lung Nourishing Cream, became eligible for reimbursement under China’s National Medical Insurance Program.

Reverse Merger Filing

Web site: http://bohaipharma.com/

Last updated January 12, 2010